2027 Healthcare Compliance Requirements: What Providers Need to Know

CMS-0057-F Final Rule Implementation

For 2027, impacted payers must stand up FHIR R4 APIs that expose core clinical, claims, and prior authorization data: Patient Access (now including non-drug PA data), Provider Access, Payer-to-Payer, and a Prior Authorization API. These APIs must use specified standards such as HL7 FHIR Release 4.0.1, USCDI, SMART App Launch, Bulk Data, and OpenID Connect. Operational changes, including public reporting and denial-reason notices, began in 2026; API compliance dates for most payers begin January 1, 2027. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

HHS has also announced enforcement discretion for the HIPAA X12 278 prior authorization transaction, allowing FHIR-only or hybrid FHIR/X12 approaches when implementing the Prior Authorization API. This flexibility reduces duplication risk as you adopt Prior Authorization Standards alongside FHIR R4 APIs. ([cms.gov](https://www.cms.gov/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

Key 2027 deliverables

• Map EHR and payer data to FHIR R4 resources and recommended Da Vinci IGs (CRD, DTR, PAS) to support end-to-end prior authorization.
• Operationalize attribution and opt-out controls for the Provider Access API, and opt-in education for Payer-to-Payer exchange.
• Harden API security (OAuth2/OpenID, consent logging) and build dashboards for Patient Access API usage metrics.

Prior Authorization Timelines and Processes

Starting January 1, 2026, impacted payers (excluding QHPs on the FFEs) must make prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests, and must provide specific denial reasons. Payers must publicly post PA metrics by March 31 each year for the prior plan year. These requirements shape 2027 workflows, appeals strategies, and transparency expectations. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

CMS also proposed aligning QHP issuers’ decision timeframes with these standards and expanding metric reporting—changes you should monitor while preparing intake, triage, and escalation protocols that withstand Unified Program Integrity Contractor Audits and minimize False Claims Act Enforcement risk. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule?utm_source=openai))

Action checklist

• Reconfigure scheduling to reflect 72-hour/7-day clocks; surface PA status in clinical worklists to prevent care delays.
• Standardize denial-reason capture to speed resubmissions and support audit defense.
• Publish payer-facing and patient-facing PA education to reduce rework and denials.

Telehealth Flexibilities Extension

Congress extended key Medicare telehealth flexibilities through December 31, 2027, sustaining broad originating-site and geographic waivers and preserving access pathways that were at risk of expiring in 2026. Use the extension window to formalize virtual-care governance, credentialing, billing, and documentation that meet payer policies and Telehealth Policy Extensions without interruption to access. ([aapmr.org](https://www.aapmr.org/members-publications/newsroom/member-news/2026/02/16/telehealth-flexibilities-extended-through-december-31--2027?utm_source=openai))

Action checklist

• Verify coverage and coding (including audio-only where allowed) across Medicare, Medicaid, and commercial plans.
• Embed virtual-care quality and fraud controls to protect against recoupments and UPIC scrutiny.
• Audit network directories and referral patterns as telehealth normalizes across service lines.

Electronic Prior Authorization for Drugs

CMS proposed requiring Medicaid, CHIP, and QHP issuers to support API-driven ePA for pharmacy benefits using NCPDP standards—SCRIPT, Formulary & Benefit, and Real-Time Prescription Benefit—beginning October 1, 2027, aligning with existing Medicare Part D ePA expectations. Plan for tighter turnaround times and greater transparency in drug PA, with bidirectional EHR-pharmacy-benefit integration. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule?utm_source=openai))

Action checklist

• Ensure your e-prescribing platform supports NCPDP SCRIPT ePA and displays real-time benefit and alternatives at order entry.
• Shift PA initiation to the point of prescribing; train staff to resolve clinical documentation gaps proactively.
• Track decision times and approvals by drug class to reduce abandonment and improve adherence.

Health Equity Index Reward Factor

While CMS had previously outlined a health equity–focused reward concept, the 2027 Medicare Advantage Star Ratings will not implement the Health Equity Index/EHO4All reward; CMS will retain the historical reward factor for 2027. Still, equity performance remains central to Star Ratings strategy—stratify outcomes for enrollees with social risk factors, expand Z-code capture, and close gaps in care to safeguard ratings and bonus revenue. ([cms.gov](https://www.cms.gov/files/document/2027-announcement.pdf))

Action checklist

• Operationalize disparity stratification and outreach for duals, LIS, and disability subgroups.
• Align care management with SDoH referrals and measure-level improvement plans that affect Medicare Advantage Star Ratings.

Non-Network Qualified Health Plans Certification

HHS proposed allowing certain non-network plans to obtain QHP certification beginning with plan year 2027, subject to access safeguards (for example, ensuring sufficient providers accept the plan’s benefit amount as payment in full and meeting essential community provider expectations). Providers should prepare for potential shifts in referral patterns and out-of-network negotiations if the proposal is finalized. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/hhs-notice-benefit-payment-parameters-2027-proposed-rule?utm_source=openai))

Action checklist

• Review financial policies for payment-in-full arrangements and surprise-billing compliance.
• Update patient estimates and consent workflows for non-network benefit designs.
• Monitor state oversight and Marketplace certification conditions that may affect local access dynamics.

HIPAA Administrative Simplification Adoption

In March 2026, HHS finalized national standards for electronic health care claims attachments and electronic signatures under Administrative Simplification, with compliance required by May 26, 2028. Build a roadmap to exchange attachment information via adopted HL7 guides and upgrade signature workflows to meet the new standard. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/administrative-simplification-adoption-standards-health-care-claims-attachments-transactions?utm_source=openai))

To reduce friction with CMS-0057-F, HHS’s National Standards Group announced enforcement discretion for the HIPAA X12 278 prior authorization standard when you implement a FHIR-based Prior Authorization API; this supports a single, modern pathway for PA while longer-term standards evolve. ([cms.gov](https://www.cms.gov/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

Summary

• By January 1, 2027, implement FHIR R4 APIs and embed prior authorization into clinical workflows; meet transparency and reporting obligations that began in 2026.
• Leverage telehealth through December 31, 2027, while hardening billing, quality, and compliance controls.
• Prepare for pharmacy ePA via NCPDP standards targeted for October 1, 2027 (proposed), and for 2028 claims-attachment mandates.
• Track evolving Star Ratings equity policy, NBPP 2027 Marketplace changes, and HIPAA Administrative Simplification to stay ahead of audits and enforcement.

FAQs.

What are the key deadlines for 2027 healthcare compliance?

January 1, 2027 is the key CMS-0057-F API compliance date for most impacted payers (Patient Access with PA data, Provider Access, Payer-to-Payer, and Prior Authorization APIs). Prior authorization metrics were first due March 31, 2026 for 2025 data and continue annually. Medicare telehealth flexibilities now run through December 31, 2027. Pharmacy ePA via NCPDP standards is proposed to begin October 1, 2027 for Medicaid, CHIP, and QHP issuers; monitor the final rule. Claims-attachment standards under HIPAA are final with a May 26, 2028 compliance date. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

How does the CMS-0057-F Final Rule affect health plans?

Health plans must modernize prior authorization and data exchange: stand up FHIR R4 APIs, add PA data to the Patient Access API, provide explicit denial reasons, and publicly report PA metrics. They must also support patient and provider education, attribution/opt-out processes, and security controls—while benefitting from HIPAA enforcement discretion that permits FHIR-first PA transactions. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f))

What is the Health Equity Index Reward Factor in Medicare Advantage?

For the 2027 Star Ratings, CMS will not implement the Health Equity Index/EHO4All reward and will retain the historical reward factor. Continue investing in equitable performance—closing gaps for beneficiaries with social risk factors—to protect ratings, bonus payments, and growth. ([cms.gov](https://www.cms.gov/files/document/2027-announcement.pdf))

How will electronic prior authorization for drugs change workflows?

If finalized as proposed, pharmacy ePA will shift work to the point of prescribing: your EHR would use NCPDP SCRIPT ePA plus Formulary & Benefit and Real-Time Prescription Benefit to submit complete requests, surface cost-effective alternatives, and accelerate determinations. Expect faster turnaround, fewer callbacks, and clearer audit trails—provided you align prescriber, pharmacy, and plan systems before the October 1, 2027 start. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/2026-cms-interoperability-standards-prior-authorization-drugs-proposed-rule?utm_source=openai))